2024년 12월 20일
Acknowledged for its achievements in global market expansion with annual exports surpassing USD 5 million
ILDONG Bioscience, a subsidiary of the ILDONG Pharmaceutical Group, announced on December 20th that it has been selected as a recipient of the prestigious ‘K-Food Plus Export Tower’ award. This award is organized by the Ministry of Agriculture, Food and Rural Affairs and the Korea Agro-Fisheries & Food Trade Corporation (aT).
The ‘K-Food Plus Export Tower’ recognizes companies that contribute to revitalizing markets and increasing exports in the agricultural, food, and related industries. The 2024 awards ceremony took place on December 18th at the aT Center in Seocho District, Seoul.
Acknowledgment of Export Excellence
According to the company, the award highlights ILDONG Bioscience’s outstanding performance in functional food and ingredient exports. Over the evaluation period from Q4 2023 to Q3 2024, the company achieved USD 5 million in annual export sales, showcasing its success in pioneering global markets.
Innovative Functional Ingredients Driving Success
ILDONG Bioscience specializes in developing and offering a wide range of functional probiotics and postbiotics targeting:
Gut health
Skin immunity
Cholesterol improvement
Body fat reduction
These cutting-edge products are crafted using proprietary technologies, including a robust database of over 5,000 microbial strains and advanced quadruple-coating technology for enhanced product efficacy and stability.
Expanding Global Presence
ILDONG Bioscience has received positive responses in key markets, including Thailand, Malaysia, and other parts of Asia, as well as in the United States and Canada. Recently, the company has further broadened its export horizons, successfully entering European markets such as Spain and Greece.
Commitment to Innovation and Quality
A company representative stated, “We are committed to developing diverse functional ingredients by leveraging our proprietary strain database and coating technologies. Additionally, we are expanding global certifications, including GRAS (Generally Recognized As Safe) approval in the U.S., to enhance our competitiveness and quality standards.”
About ILDONG Bioscience
Founded in 2016 as a part of ILDONG Holdings, ILDONG Bioscience leverages the foundational probiotic technologies and infrastructure of ILDONG Pharmaceutical. The company focuses on the development of functional ingredients and products using probiotics and postbiotics, while also offering contract development and manufacturing (CDMO) services and raw material supply.
Through its unwavering dedication to innovation and global market expansion, ILDONG Bioscience continues to solidify its position as a leader in the functional food industry.